Study guide

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics

NPLEX Part I — Biomedical Sciences Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Pacing, and GEA Strategy

1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards

2 Chapter 2: Gross Anatomy & Musculoskeletal System

2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures

3 Chapter 3: Histology & Microscopic Anatomy

3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium

4 Chapter 4: Neuroanatomy & Special Senses

4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation

5 Chapter 5: Embryology & Developmental Anatomy

5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology

6 Chapter 6: Cellular & General Physiology

6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle

7 Chapter 7: Cardiovascular & Respiratory Physiology

7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing

8 Chapter 8: Renal, Fluid, & Acid-Base Physiology

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology

9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation

10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism

10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport

11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics

11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics

12 Chapter 12: Immunology & Immunopathology

12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types

13 Chapter 13: Medical Microbiology

13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens

14 Chapter 14: General Pathology & Neoplasia

14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors

15 Chapter 15: Systems Pathology & Disease Mechanisms

15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics

Key Takeaways Explain This Topic AI

Glomerular Filtration Rate (GFR) is governed by Starling forces: GFR = Kf * [(Pgc - Pbs) - (pi_gc - pi_bs)], with glomerular capillary hydrostatic pressure (Pgc) as the primary regulated variable.

Afferent arteriole constriction decreases both GFR and Renal Plasma Flow (RPF) keeping Filtration Fraction (FF = GFR/RPF) constant, while efferent arteriole dilation lowers Pgc, decreasing GFR while increasing RPF and thus lowering FF.

The Proximal Convoluted Tubule (PCT) reabsorbs ~67% of filtered Na+, water, and HCO3-, and 100% of glucose and amino acids up to transport maximum (Tm).

Inulin clearance equals GFR (freely filtered, neither reabsorbed nor secreted), while PAH clearance measures effective Renal Plasma Flow (RPF).

Tubuloglomerular Feedback (TGF) by macula densa cells senses luminal NaCl via NKCC2 to release adenosine, constricting afferent arterioles when GFR rises.

Last updated: July 2026

8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics

The kidneys process approximately 180 liters of plasma daily through glomerular capillaries, reabsorbing over 99% of filtered water and solutes while selectively secreting metabolic waste products and xenobiotics. Understanding glomerular hemodynamics, Starling forces, renal clearance, autoregulation mechanisms, solute transport kinetics, and segmental nephron channels is fundamental to renal physiology and NPLEX Part I preparation.

Glomerular Filtration Mechanics and Starling Forces

Glomerular Filtration Rate (GFR) is governed by the Starling equation: GFR = K f ⋅ [ ( P gc − P bs ) − ( σ π gc − σ π bs ) ] \text{GFR} = K_f \cdot \left[ (P_{\text{gc}} - P_{\text{bs}}) - (\sigma \pi_{\text{gc}} - \sigma \pi_{\text{bs}}) \right] GFR = K f ​ ⋅ [ ( P gc ​ − P bs ​ ) − ( σ π gc ​ − σ π bs ​ ) ]

Where:

K f K_f K f ​ : Ultrafiltration coefficient, determined by glomerular capillary surface area and hydraulic permeability (reduced in chronic glomerulonephritis or diabetic nephropathy).

P gc P_{\text{gc}} P gc ​ : Glomerular capillary hydrostatic pressure ( ≈ 45 – 50 mmHg \approx 45–50\text{ mmHg} ≈ 45–50 mmHg ), the primary physiological regulated variable.

P bs P_{\text{bs}} P bs ​ : Bowman's space hydrostatic pressure ( ≈ 10 mmHg \approx 10\text{ mmHg} ≈ 10 mmHg ), markedly increased in urinary tract obstruction (e.g., nephrolithiasis or BPH).

π gc \pi_{\text{gc}} π gc ​ : Glomerular capillary oncotic pressure ( ≈ 25 – 35 mmHg \approx 25–35\text{ mmHg} ≈ 25–35 mmHg ), which progressively rises along the capillary length as protein-free filtrate leaves the vascular space.

π bs \pi_{\text{bs}} π bs ​ : Bowman's space oncotic pressure ( ≈ 0 mmHg \approx 0\text{ mmHg} ≈ 0 mmHg in health, as proteins are excluded by the filtration barrier).

Arteriolar Resistance Controls on GFR and RPF

Filtration Fraction (FF) is defined as the fraction of renal plasma flow (RPF) filtered into Bowman's space: FF = GFR RPF \text{FF} = \frac{\text{GFR}}{\text{RPF}} FF = RPF GFR ​

Changes in afferent and efferent arteriolar vascular tone exert distinct effects on glomerular hydrostatic pressure ( P gc P_{\text{gc}} P gc ​ ), GFR, RPF, and FF:

Arteriolar Action Glomerular Hydrostatic ( P gc P_{\text{gc}} P gc ​ ) GFR RPF Filtration Fraction (FF) Primary Mediators / Triggers

Afferent Constriction Decreases Decreases Decreases Unchanged NSAIDs (inhibit PG-mediated dilation), Sympathetic tone, Adenosine (TGF)

Efferent Constriction Increases Increases Decreases Increases Low-dose Angiotensin II (maintains GFR during hypoperfusion)

  • Efferent Dilation Decreases Decreases Increases Decreases ACE inhibitors, Angiotensin Receptor Blockers (ARBs)
  • Afferent Dilation Increases Increases Increases Unchanged ANP, BNP, High-protein meal, Nitric Oxide
  • Autoregulation of GFR: Myogenic Mechanism & Tubuloglomerular Feedback

Renal Blood Flow (RBF) and GFR remain relatively constant across systemic arterial blood pressures ranging between 80 mmHg 80\text{ mmHg} 80 mmHg and 180 mmHg 180\text{ mmHg} 180 mmHg via two intrinsic autoregulatory mechanisms:

Myogenic Mechanism : Increased systemic arterial pressure stretches vascular smooth muscle cells in afferent arterioles. Mechanosensitive ion channels depolarize the cell membrane, opening voltage-gated calcium channels ( L L L -type), causing immediate vasoconstriction to limit distal flow.

Tubuloglomerular Feedback (TGF) : Macula densa cells in the early distal convoluted tubule sense luminal Na + \text{Na}^+ Na + and Cl − \text{Cl}^- Cl − delivery via apical NKCC2 cotransporters. When GFR rises, increased fluid flow elevates luminal NaCl \text{NaCl} NaCl delivery to the macula densa. Intracellular Na + \text{Na}^+ Na + and Cl − \text{Cl}^- Cl − accumulation triggers ATP release across the basolateral membrane, which is rapidly hydrolyzed to adenosine. Adenosine binds A 1 A_1 A 1 ​ receptors on adjacent afferent arteriolar smooth muscle, inducing cytosolic Ca 2 + \text{Ca}^{2+} Ca 2 + elevation and selective afferent arteriolar constriction, returning GFR and RPF to homeostatic baselines.

Renal Clearance and Flow Measurements

Renal Clearance ( C x C_x C x ​ ) represents the volume of plasma completely cleared of substance x x x per unit time: C x = U x ⋅ V P x C_x = \frac{U_x \cdot V}{P_x} C x ​ = P x ​ U x ​ ⋅ V ​

Where U x U_x U x ​ is urinary concentration, V V V is urine flow rate, and P x P_x P x ​ is plasma concentration.

Inulin Clearance ( C inulin C_{\text{inulin}} C inulin ​ ) : Gold standard for measuring GFR ( C inulin = GFR ≈ 125 mL/min C_{\text{inulin}} = \text{GFR} \approx 125\text{ mL/min} C inulin ​ = GFR ≈ 125 mL/min ). Inulin is freely filtered, non-toxic, and neither reabsorbed nor secreted.

Creatinine Clearance ( C cr C_{\text{cr}} C cr ​ ) : Endogenous clinical surrogate for GFR. Creatinine is freely filtered with a small amount of proximal tubular secretion, slightly overestimating true GFR by 10 – 15 % 10–15\% 10–15% .

Para-aminohippuric Acid Clearance ( C PAH C_{\text{PAH}} C PAH ​ ) : Measures Effective Renal Plasma Flow ( C PAH = RPF ≈ 600 – 700 mL/min C_{\text{PAH}} = \text{RPF} \approx 600–700\text{ mL/min} C PAH ​ = RPF ≈ 600–700 mL/min ). PAH is freely filtered and actively secreted by organic anion transporters (OATs) in the PCT.

Renal Blood Flow (RBF) : Calculated from RPF and hematocrit (Hct): RBF = RPF 1 − Hct ≈ 1.2 L/min ( 20 – 25 % of cardiac output ) \text{RBF} = \frac{\text{RPF}}{1 - \text{Hct}} \approx 1.2\text{ L/min} \quad (20\text{--}25\% \text{ of cardiac output}) RBF = 1 − Hct RPF ​ ≈ 1.2 L/min ( 20 – 25% of cardiac output )

Glucose Transport Kinetics: SGLT2/SGLT1, Transport Maximum ( T m T_m T m ​ ), and Splay

Glucose is freely filtered at the glomerulus and fully reabsorbed in the Proximal Convoluted Tubule under physiological conditions:

Apical Transport : Secondary active transport via SGLT2 (high-capacity, low-affinity cotransporter in S1 segment, reabsorbing 90 % 90\% 90% ) and SGLT1 (low-capacity, high-affinity cotransporter in S3 segment, reabsorbing 10 % 10\% 10% ).

Basolateral Transport : Facilitated diffusion via GLUT2 (S1) and GLUT1 (S3).

Transport Maximum ( T m T_m T m ​ ) : The saturation point of glucose transporters, averaging 375 mg/min 375\text{ mg/min} 375 mg/min in males ( 300 mg/min 300\text{ mg/min} 300 mg/min in females).

Renal Threshold : The plasma glucose level at which glucose first appears in the urine ( ≈ 180 – 200 mg/dL \approx 180–200\text{ mg/dL} ≈ 180–200 mg/dL ).

Splay : The gradual rounding of the glucose reabsorption curve between the renal threshold ( 180 mg/dL 180\text{ mg/dL} 180 mg/dL ) and true T m T_m T m ​ ( 375 mg/min 375\text{ mg/min} 375 mg/min ). Splay results from nephron heterogeneity (varying GFR and transporter density among individual nephrons) and carrier dissociation kinetics.

Fractional Excretion of Sodium ( F E Na FE_{\text{Na}} F E Na ​ ) and Clinical Applications

Fractional Excretion of Sodium compares the mass of sodium excreted in urine against the mass filtered by the glomerulus: F E Na = Sodium Excreted Sodium Filtered = U Na ⋅ P cr P Na ⋅ U cr × 100 % FE_{\text{Na}} = \frac{\text{Sodium Excreted}}{\text{Sodium Filtered}} = \frac{U_{\text{Na}} \cdot P_{\text{cr}}}{P_{\text{Na}} \cdot U_{\text{cr}}} \times 100\% F E Na ​ = Sodium Filtered Sodium Excreted ​ = P Na ​ ⋅ U cr ​ U Na ​ ⋅ P cr ​ ​ × 100%

F E Na < 1 % FE_{\text{Na}} < 1\% F E Na ​ < 1% : Indicates Prerenal Azotemia (renal hypoperfusion with intact tubular reabsorption mechanisms, where nephrons avidly conserve sodium and water).

F E Na > 2 % FE_{\text{Na}} > 2\% F E Na ​ > 2% : Indicates Intrinsic Acute Kidney Injury (such as Acute Tubular Necrosis / ATN, where tubular cell necrosis impairs sodium reabsorption capacity).

Segmental Nephron Transport Mechanics

Proximal Convoluted Tubule (PCT) :

Reabsorbs ≈ 67 % \approx 67\% ≈ 67% of filtered Na + \text{Na}^+ Na + , Cl − \text{Cl}^- Cl − , H 2 O \text{H}_2\text{O} H 2 ​ O , and HCO 3 − \text{HCO}_3^- HCO 3 − ​ , and 100 % 100\% 100% of glucose and amino acids.

Iso-osmotic reabsorption driven by basolateral Na + / K + \text{Na}^+/\text{K}^+ Na + / K + -ATPase. Carbonic anhydrase (IV on lumen, II intracellular) generates HCO 3 − \text{HCO}_3^- HCO 3 − ​ reabsorption.

Thick Ascending Limb of Henle (TAL) :

Reabsorbs ≈ 25 % \approx 25\% ≈ 25% of filtered Na + \text{Na}^+ Na + , K + \text{K}^+ K + , Cl − \text{Cl}^- Cl − via apical NKCC2 cotransporter (inhibited by loop diuretics like furosemide).

Impermeable to water. Apical ROMK potassium backleak generates a lumen-positive electrical potential ( + 10 – 20 mV +10–20\text{ mV} + 10–20 mV ) driving paracellular Ca 2 + \text{Ca}^{2+} Ca 2 + and Mg 2 + \text{Mg}^{2+} Mg 2 + reabsorption.

Distal Convoluted Tubule (DCT) :

Reabsorbs 5 – 8 % 5–8\% 5–8% of filtered Na + \text{Na}^+ Na + and Cl − \text{Cl}^- Cl − via apical NCCT cotransporter (inhibited by thiazides).

PTH stimulates active basolateral Ca 2 + \text{Ca}^{2+} Ca 2 + reabsorption via apical TRPV5 channels.

Collecting Duct :

Principal Cells : Reabsorb Na + \text{Na}^+ Na + via apical ENaC channels and secrete K + \text{K}^+ K + via ROMK under Aldosterone regulation. ADH inserts Aquaporin-2 (AQP2) channels into apical membranes.

α \alpha α -Intercalated Cells : Secrete H + \text{H}^+ H + via H + \text{H}^+ H + -ATPase and H + / K + \text{H}^+/\text{K}^+ H + / K + -ATPase to regulate acid-base equilibrium and reabsorb K + \text{K}^+ K + .

Hereditary Tubular Transport Disorders

Disorder Inherited Mutation Nephron Segment / Channel Clinical Features & Electrolyte Picture

Fanconi Syndrome Generalized PCT impairment Proximal Convoluted Tubule Phosphaturia, glucosuria, aminoaciduria, Type 2 RTA, hypokalemia, osteomalacia

Bartter Syndrome AR loss-of-function TAL (NKCC2, ROMK, or CLCNKB) Mimics loop diuretic abuse: hypokalemia, metabolic alkalosis, hypercalciuria, normal/low BP

Gitelman Syndrome AR loss-of-function DCT (NCCT cotransporter) Mimics thiazide abuse: hypokalemia, metabolic alkalosis, hypocalciuria, hypomagnesemia

Liddle Syndrome AD gain-of-function Principal cell (ENaC channels) Uninhibited Na+ reabsorption: severe hypertension, hypokalemia, metabolic alkalosis, suppressed renin & aldosterone

Apparent Mineralocorticoid Excess (AME) AR 11 β 11\beta 11 β -HSD2 deficiency Principal cell ( 11 β 11\beta 11 β -HSD2 enzyme) Cortisol activates mineralocorticoid receptors: hypertension, hypokalemia, metabolic alkalosis, low renin & aldosterone (can be acquired via licorice)